<?xml version="1.0" encoding="utf-8"?>
<rdf:RDF
  xmlns:ns1="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#"
  xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
  xmlns:owl="http://www.w3.org/2002/07/owl#"
  xmlns:ns2="http://ontology.test.es/comment#"
  xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#insuficiente_adh_espa">
    <rdfs:subClassOf>
      <rdf:Description rdf:about="http://www.w3.org/2002/07/owl#Thing">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">THING</rdfs:label>
      </rdf:Description>
    </rdfs:subClassOf>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">insuficiente_adh_espa</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_ESP</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_ESP</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#interacciones_medicamentosas">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">interacciones_medicamentosas</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NTERACCIONES_MEDICAMENTOSA</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NTERACCIONES_MEDICAMENTOSA</ns2:definition>
  </owl:Class>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#A1">
    <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AnnotationProperty"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Role_Has_Domain</rdfs:label>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43803"/>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43794"/>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43802"/>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43796"/>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43793"/>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43799"/>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43800"/>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43789"/>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43801"/>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43790"/>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43792"/>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43791"/>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43798"/>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43797"/>
    <rdfs:range rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
  </owl:ObjectProperty>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#mars">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mars</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">AR</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">AR</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#indisponibilidaddetratamientoefectivo">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">indisponibilidaddetratamientoefectivo</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NDISPONIBILIDADDETRATAMIENTOEFECTIV</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NDISPONIBILIDADDETRATAMIENTOEFECTIV</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#interacciones">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">interacciones</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NTERACCIONE</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NTERACCIONE</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Inhalador">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Dispositivos_electronicos"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inhalador</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'- Definición de la Real Academia Nacional de Medicina de 'Inhalador':

 Dispositivo que se utiliza para suministrar medicación que llegue directamente a los pulmones, con lo que se consigue una mayor eficacia, pues el fármaco actúa directamente en el lugar de la enfermedad, y menores efectos secundarios. Se emplea fundamentalmente con broncodilatadores y esteroides en enfermedades como el asma, la enfermedad pulmonar obstructiva crónica y la fibrosis quística. Existen dos tipos: presurizados y de polvo seco. El inhalador presurizado precisa de la colaboración de los pacientes, pues debe presionar el dispositivo al mismo tiempo que hace una inspiración máxima. El inhalador en polvo seco se activa con la inspiración de los pacientes y se libera la medicación que, de esta forma, a través del aire inspirado, penetra en los pulmones. En estos dispositivos, la eficacia está asegurada aunque los enfermos no hagan correctamente la maniobra de la inspiración.', '334980009 | Inhalador |', 'Diferencia del peso inicial y final en dispositivos inhaladores.

El método (indirecto) parte de la medida del aparato inhalador, en una primera visita, en una balanza de precisión. Posteriormente, se volverá a pesar el inhalador tras un tiempo determinado de uso para comparar la diferencia de pesos. Con este diferencial, se puede deducir el uso que el paciente ha hecho del aparato. Conocido el regimiento terapéutico indicado y el costo en peso de una aplicación del dispositivo, se puede hacer una valoración de la adherencia. Algunos aspectos a tener en cuenta son que es necesario que el paciente sepa utilizar el aparato correctamente y que la medida del dispositivo es compleja y requiere personal capacitado para ello, material adecuado y tiempo [1]. 

Puede ser también considerado como un método de conteo de píldoras [2].

Otra forma de comprobar el cumplimiento de la terapia con inhaladores es utilizar SmartTrack que es una aplicación que registra la fecha y la hora en la que el paciente se ha tomado el tratamiento y carga los datos en su sitio web. También envía mensajes recordatorios cuando se ha olvidado tomar [3].

[1] Rodríguez Chamorro, M. Á., García-Jiménez, E., Gil, A. B., Chamorro, A. R., Pérez Merino, E. M., Faus Dáder, M. J., &amp; Martínez Martínez, F. (2009). Herramientas para identificar el incumplimiento farmacoterapéutico desde la farmacia comunitaria Tools for the identification by community pharmacies of pharmacotherapeutic non-compliance. Pharmaceutical Care España, 11(4), 183–191.
[2] Lam, W. Y., &amp; Fresco, P. (2015). Medication Adherence Measures: An Overview. BioMed Research International. e217047. https://doi.org/10.1155/2015/217047
[3] Davies, M. J., Kotadia, A., Mughal, H., Hannan, A., &amp; Alqarni, H. (2015). The attitudes of pharmacists, students and the general public on mHealth applications for medication adherence. Pharmacy practice, 13(4).'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_SP</ns2:ontology_acronm>
  </owl:Class>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R53">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Plays_Role_In_Biological_Process</rdfs:label>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
  </owl:ObjectProperty>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlos/ontologies/2019/3/untitled-ontology-31#MAQ">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlos/ontologies/2019/3/untitled-ontology-31#Questionnaries_and_scales"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">MAQ</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Morisky Medication Adherence Questionnaire (MAQ) - Morisky Medication Adherence Scale (MMAS-4)

It is a widely used and validated questionnaire in numerous studies that compare results with the use of MEMS, pill counting, drug dispensing records in pharmacies, and clinical evaluation. The questionnaire (developed by Green et al. [1]) has four dichotomous 'yes/no' questions where the first two address unintentional nonadherence (e.g., when there is forgetfulness or lack of care) and the next two antiadherence to intentional nonadherence (e.g., when medication is discontinued due to improvement or worsening of symptoms). 

It is used to evaluate chronic diseases such as diabetes, hypertension or heart failure [2], among others, as it reflects the patient's behaviour with respect to compliance. It is brief and easy to apply, without demanding socio-cultural requirements and with great sensitivity (81%) although not so much specificity (44%) [6].  However, there are also studies that do not confirm the satisfactory use of this questionnaire as an adherence meter [3,4]. The questionnaire consists of the following questions:

Do you ever forget to take your medicine?
2. Are you careless at times about taking your medicine?
3. When you feel better, do you sometimes stop taking your medicine?
4. Sometimes if you feel worse when you take the medicine, do you stop taking it?

Analysis results: each negative response is scored with 0 and each positive response with 1, so that a total score of 0 indicates a high degree of adherence, 1 or 2 total points indicates average adherence and 3 or more, lack of adherence [1]. It is a type of indirect indicator [5].

We found in Spanish a version in which the answers that would demonstrate adherence would be 'no-yes-no-no' [5].

[1] Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care. 1986;24:67–74. 
[2] Nguyen, T. M. U., Caze, A. La, &amp; Cottrell, N. (2014). What are validated self-report adherence scales really measuring?: A systematic review. British Journal of Clinical Pharmacology, 77(3), 427–445. https://doi.org/10.1111/bcp.12194
[3]Van De Steeg, N., Sielk, M., Pentzek, M., Bakx, C., &amp; Altiner, A. (2009). Drug-adherence questionnaires not valid for patients taking blood-pressure-lowering drugs in a primary health care setting. Journal of Evaluation in Clinical Practice, 15(3), 468–472. https://doi.org/10.1111/j.1365-2753.2008.01038.x
[4] Wang, Y., Lee, J., Toh, M. P. H. S., Tang, W. E., &amp; Ko, Y. (2012). Validity and reliability of a self-reported measure of medication adherence in patients with Type2 diabetes mellitus in Singapore. Diabetic Medicine, 29(9), 338–344. https://doi.org/10.1111/j.1464-5491.2012.03733.x
[5] Chamorro, M. A. R., García-Jiménez, E., Amariles, P., &amp; Faus, M. J. (2008). Revisión de tests de medición del cumplimiento terapéutico utilizados en la práctica clínica. Aten Primaria, 40(8), 413–417.
[6] Tan, X., Patel, I., &amp; Chang, J. (2014). Review of the four item Morisky Medication Adherence Scale (MMAS-4) and eight item Morisky Medication Adherence Scale (MMAS-8). Innovations in Pharmacy, 5(3), 0–8. https://doi.org/10.1111/dme.12651'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_EN</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#inmigrante">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">inmigrante</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NMIGRANT</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NMIGRANT</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#insuficiente_adh_asrq_nivel6">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">insuficiente_adh_asrq_nivel6</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_ASRQ_NIVEL</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_ASRQ_NIVEL</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#insuficiente_adh_asrq_nivel4">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">insuficiente_adh_asrq_nivel4</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_ASRQ_NIVEL</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_ASRQ_NIVEL</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#lejania_punto_acceso_servicio_sanitario">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lejania_punto_acceso_servicio_sanitario</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">EJANIA_PUNTO_ACCESO_SERVICIO_SANITARI</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">EJANIA_PUNTO_ACCESO_SERVICIO_SANITARI</ns2:definition>
  </owl:Class>
  <owl:AnnotationProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#code">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">code</rdfs:label>
  </owl:AnnotationProperty>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#mmas-8">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mmas-8</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">MAS-</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">MAS-</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#insuficiente_adh_smaq">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">insuficiente_adh_smaq</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_SMA</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_SMA</ns2:definition>
  </owl:Class>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R52">
    <rdfs:range rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Has_Biochemical_Function</rdfs:label>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
  </owl:ObjectProperty>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#intervenciones">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">intervenciones</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NTERVENCIONE</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NTERVENCIONE</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#insuficiente_adh_mars">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">insuficiente_adh_mars</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_MAR</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_MAR</ns2:definition>
  </owl:Class>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R54">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Encoded_By_Gene</rdfs:label>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
  </owl:ObjectProperty>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Intervenciones">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Adherencia_medicacion"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Intervenciones</rdfs:label>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_SP</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlos/ontologies/2019/3/untitled-ontology-31#MMAS-8">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlos/ontologies/2019/3/untitled-ontology-31#Questionnaries_and_scales"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">MMAS-8</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Scale of adherence to medication 'Morisky-8' or Eight-Item Morisky Medication Adherence Scale (MMAS-8)

In 2008, the MMAS-8 scale is published, which consists of 8 items in total, where the first seven allow you to answer only 'yes' or 'no' and the last one is a Likert item of 5 options. It has greater specificity than its MMAS-4 version and allows us to know the reasons or situations behind adhesion problems [2]. It is a type of scale validated by comparison with pharmaceutical registers and by clinical evaluation [3] and with greater validity and degree of confidence for treating chronic patients than with the MAQ questionnaire [4]. The scale focused on hypertension is as follows [2]:

Do you sometimes forget to take your high blood pressure pills?	
2. Over the past two weeks, were there any days when you did not take your high blood pressure medicine?
3. Have you ever cut back or stopped taking your medication without telling your doctor because you felt worse when you took it?
4. When you travel or leave home, do you sometimes forget to bring along your medications?
5. Did you take your high blood pressure medicine yesterday?
6. When you feel like your blood pressure is under control, do you sometimes stop taking your medicine?
7. Taking medication everyday is a real inconvenience for some people. Do you ever feel hassled about sticking to your blood pressure treatment plan?
8. How often do you have difficulty remembering to take all your blood pressure medication?

Analysis of the results [5]:
Questions answered as 'no' get zero points and affirmative answers get one point. A final score of 3-8 points is considered low adherence. 

[1] Muntner P, Joyce C, Holt E, et al. (2011). Defining the minimal detectable change in scores on the eight-item Morisky Medication Adherence Scale. Ann. Pharmacother. 45(5):569–575.
[2] Morisky, D. E., Ang, A., Krousel-Wood, M., &amp; Ward, H. J. (2008). Predictive validity of a medication adherence measure in an outpatient setting. Journal of Clinical Hypertension, 10(5), 348–354. https://doi.org/10.1111/j.1751-7176.2008.07572.x
[3] Nguyen, T. M. U., Caze, A. La, &amp; Cottrell, N. (2014). What are validated self-report adherence scales really measuring?: A systematic review. British Journal of Clinical Pharmacology, 77(3), 427–445. https://doi.org/10.1111/bcp.12194
[4] Lam, W. Y., &amp; Fresco, P. (2015). Medication Adherence Measures: An Overview. BioMed Research International, e217047. https://doi.org/10.1155/2015/217047
[5] Capoccia, K., Odegard, P. S., &amp; Letassy, N. (2016). Medication Adherence With Diabetes Medication: A Systematic Review of the Literature. The Diabetes Educator, 42(1), 34–71. https://doi.org/10.1177/0145721715619038'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_EN</ns2:ontology_acronm>
  </owl:Class>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#A2">
    <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AnnotationProperty"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Role_Has_Range</rdfs:label>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43794"/>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43793"/>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43734"/>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43801"/>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43740"/>
    <rdfs:range rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
  </owl:ObjectProperty>
  <owl:AnnotationProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P366">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Legacy_Concept_Name</rdfs:label>
  </owl:AnnotationProperty>
  <owl:Class rdf:about="http://identifiers.org/ncbigene/216443">
    <rdfs:subClassOf rdf:resource="http://semanticscience.org/resource/SIO_010035"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mars</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Metrs, Mtrns</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'The protein-coding gene Mars (methionine-tRNA synthetase) located on the chromosome 10 mapped at 10 D3|10.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GEXO</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#insuficiente_adh_asrq_nivel3">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">insuficiente_adh_asrq_nivel3</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_ASRQ_NIVEL</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_ASRQ_NIVEL</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#interactuante">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">interactuante</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NTERACTUANT</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NTERACTUANT</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#insuficiente_adh_haynes_sackett">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">insuficiente_adh_haynes_sackett</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_HAYNES_SACKET</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_HAYNES_SACKET</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#insuficiencia_renal">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">insuficiencia_renal</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENCIA_RENA</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENCIA_RENA</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#insuficiente_adh_maq">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">insuficiente_adh_maq</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_MA</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_MA</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#juicio_farmaceutico">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">juicio_farmaceutico</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">UICIO_FARMACEUTIC</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">UICIO_FARMACEUTIC</ns2:definition>
  </owl:Class>
  <owl:AnnotationProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P90">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">FULL_SYN</rdfs:label>
  </owl:AnnotationProperty>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#insuficiente_adh_batalla">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">insuficiente_adh_batalla</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_BATALL</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_BATALL</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Interactuante">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Interacciones"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Interactuante</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Definición de la Real Academia Española de 'Interactuar':

Actuar recíprocamente.', 'Este elemento puede usarse para describir el medicamento específico, comida o prueba de laboratorio que actúan como el segundo interactuante de la interacción tal y como se describe en la información reglamentaria del producto.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_SP</ns2:ontology_acronm>
  </owl:Class>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R133">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Has_Abnormality</rdfs:label>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:about="http://semanticscience.org/resource/SIO_000426">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">is manifestation of</rdfs:label>
    <rdfs:domain rdf:resource="http://semanticscience.org/resource/SIO_000003"/>
  </owl:ObjectProperty>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C128475">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C17728"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Membrane-Associated Progesterone Receptor Component 1</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Membrane-Associated Progesterone Receptor Component 1, PGRMC1, mPR, Progesterone Binding Protein</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Membrane-associated progesterone receptor component 1 (195 aa, ~22 kDa) is encoded by the human PGRMC1 gene. This protein may play a role in progesterone uptake.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlos/ontologies/2019/3/untitled-ontology-31#MUAH">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlos/ontologies/2019/3/untitled-ontology-31#Questionnaries_and_scales"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">MUAH</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire

This is a questionnaire developed from interviews with hypertensive patients. A total of 44 relevant items were collected and included in the questionnaire. All items were scaled according to a Likert scale of seven points ranging from 'totally disagree' (1) to 'totally agree' (7). It is a validated questionnaire having been compared with other adherence meters (MEMS, BMQ and pharmacy records) [2] although its own authors suggested that it would need further analysis due to the difficulty of interpreting convergence results [1]. 

However, the fact that data on convergent validity are difficult to interpret points to the need to validate the MUAH questionnaire in other studies.

[1] Wetzels G, Nelemans P, van Wijk B, Broers N, Schouten J, Prins M. (2006). Determinants of poor adherence in hypertensive patients: development and validation of the ‘Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire’. Patient Educ Counsel. 64: 151–8. https://doi.org/10.1016/j.pec.2005.12.010
[2] Nguyen, T. M. U., Caze, A. La, &amp; Cottrell, N. (2014). What are validated self-report adherence scales really measuring?: A systematic review. British Journal of Clinical Pharmacology, 77(3), 427–445. https://doi.org/10.1111/bcp.12194'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_EN</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#muah">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">muah</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">UA</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">UA</ns2:definition>
  </owl:Class>
  <owl:AnnotationProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P368">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">CHEBI_ID</rdfs:label>
  </owl:AnnotationProperty>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R49">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Expressed_In_Tissue</rdfs:label>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
  </owl:ObjectProperty>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#IndisponibilidadDeTratamientoEfectivo">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Condicion"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IndisponibilidadDeTratamientoEfectivo</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Definición de la Real Academia Española de 'Disponibilidad':

- Cualidad o condición de disponible.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_SP</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#insuficiente_adh_bmq">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">insuficiente_adh_bmq</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_BM</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_BM</ns2:definition>
  </owl:Class>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R44">
    <rdfs:range rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Has_Chemical_Classification</rdfs:label>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R42">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Is_Biomarker_Type</rdfs:label>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
  </owl:ObjectProperty>
  <owl:AnnotationProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P97">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DEFINITION</rdfs:label>
  </owl:AnnotationProperty>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Inmigrante">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Sociodemograficos"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inmigrante</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'161158003 | Inmigrante |', 'Definición de la Real Academia Española de 'Inmigrante':

Que inmigra.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_SP</ns2:ontology_acronm>
  </owl:Class>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R47">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Is_Biomarker_Of</rdfs:label>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#A7">
    <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AnnotationProperty"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Has_Target</rdfs:label>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C60769"/>
    <rdfs:range rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C17021"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R48">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Malfunction_Associated_With_Disease</rdfs:label>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
  </owl:ObjectProperty>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#insuficiente_adh_bogus_pipeline">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">insuficiente_adh_bogus_pipeline</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_BOGUS_PIPELIN</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_BOGUS_PIPELIN</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#inhalador">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">inhalador</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NHALADO</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NHALADO</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#mpr">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mpr</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">P</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">P</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#insuficiente_adh_asrq_nivel5">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">insuficiente_adh_asrq_nivel5</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_ASRQ_NIVEL</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_ASRQ_NIVEL</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Indirecto">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Directo/indirecto"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Indirecto</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'- Definición de la Real Academia Española de 'Indirecto':

Que no va rectamente a un fin, aunque se encamine a él.', 'Los métodos considerados aplicables en la práctica clínica son, mayormente, de tipo indirecto. Esto se debe a que, a pesar de no ser los más fiables, son más baratos y sencillos de ejecutar [1].  Existen numerosos métodos indirectos (más que directos) y consiguen con mayor o menor acierto una aproximación a la realidad del resultado según se elija el método para cada situación [2]. 
Además, permiten no sólo deducir si el paciente es adherente o no, si no también nos acerca a ver el 'por qué' de su nivel de adherencia, puesto que reflejan formas y hábitos de conductas al permitir un rango de respuestas del paciente más alla de 'sí cumple esto' o 'no cumple esto' [1]. 
ref: revision

[1] Rodríguez Chamorro, M. Á., García-Jiménez, E., Gil, A. B., Chamorro, A. R., Pérez Merino, E. M., Faus Dáder, M. J., &amp; Martínez Martínez, F. (2009). Herramientas para identificar el incumplimiento farmacoterapéutico desde la farmacia comunitaria Tools for the identification by community pharmacies of pharmacotherapeutic non-compliance. Pharmaceutical Care España, 11(4), 183–191.
[2] Lee, C. S., Tan, J. H. M., Sankari, U., Koh, Y. L. E., &amp; Tan, N. C. (2017). Assessing oral medication adherence among patients with type 2 diabetes mellitus treated with polytherapy in a developed Asian community: a cross-sectional study. BMJ Open, 7(9), e016317. https://doi.org/10.1136/bmjopen-2017-016317', '255541007 | Indirecto |'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_SP</ns2:ontology_acronm>
  </owl:Class>
  <owl:AnnotationProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P325">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ALT_DEFINITION</rdfs:label>
  </owl:AnnotationProperty>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#interacciones_y_alergias">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">interacciones_y_alergias</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NTERACCIONES_Y_ALERGIA</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NTERACCIONES_Y_ALERGIA</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#maq">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">maq</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A</ns2:definition>
  </owl:Class>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#mala_calidad_sue">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mala_calidad_sue</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ALA_CALIDAD_SU</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ALA_CALIDAD_SU</ns2:definition>
  </owl:Class>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R122">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chemical_Or_Drug_Is_Metabolized_By_Enzyme</rdfs:label>
    <rdfs:range rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
  </owl:ObjectProperty>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#insuficiente_adh_hermes">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">insuficiente_adh_hermes</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_HERME</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NSUFICIENTE_ADH_HERME</ns2:definition>
  </owl:Class>
  <owl:AnnotationProperty rdf:about="http://ontology.test.es/comment#ontology_acronm">
    <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2000/01/rdf-schema#comment"/>
  </owl:AnnotationProperty>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#llamada_telefonica">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">llamada_telefonica</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">LAMADA_TELEFONIC</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">LAMADA_TELEFONIC</ns2:definition>
  </owl:Class>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R146">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chemical_Or_Drug_Affects_Gene_Product</rdfs:label>
    <rdfs:range rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R45">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Has_Organism_Source</rdfs:label>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R50">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Has_Structural_Domain_Or_Motif</rdfs:label>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
  </owl:ObjectProperty>
  <owl:AnnotationProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P98">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DesignNote</rdfs:label>
  </owl:AnnotationProperty>
  <owl:Class rdf:about="http://ontologies.khaos.uma.es#lenguaje_tecnico_y_complejo">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lenguaje_tecnico_y_complejo</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ENGUAJE_TECNICO_Y_COMPLEJ</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ENGUAJE_TECNICO_Y_COMPLEJ</ns2:definition>
  </owl:Class>
  <owl:AnnotationProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P108">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Preferred_Name</rdfs:label>
  </owl:AnnotationProperty>
  <owl:AnnotationProperty rdf:about="http://ontology.test.es/comment#definition">
    <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2000/01/rdf-schema#comment"/>
  </owl:AnnotationProperty>
  <owl:AnnotationProperty rdf:about="http://ontology.test.es/comment#synonym">
    <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2000/01/rdf-schema#comment"/>
  </owl:AnnotationProperty>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R46">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Has_Associated_Anatomy</rdfs:label>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R131">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Is_Element_In_Pathway</rdfs:label>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R51">
    <rdfs:range rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Is_Physical_Part_Of</rdfs:label>
    <rdfs:domain rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
  </owl:ObjectProperty>
  <owl:AnnotationProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P207">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">UMLS_CUI</rdfs:label>
  </owl:AnnotationProperty>
  <owl:ObjectProperty rdf:about="http://semanticscience.org/resource/SIO_000341">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">is manifested as</rdfs:label>
    <rdfs:range rdf:resource="http://semanticscience.org/resource/SIO_000003"/>
  </owl:ObjectProperty>
  <owl:AnnotationProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P310">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Concept_Status</rdfs:label>
  </owl:AnnotationProperty>
  <owl:AnnotationProperty rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P106">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Semantic_Type</rdfs:label>
  </owl:AnnotationProperty>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43796">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43643"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Has_Organism_Source</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Has_Organism_Source</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A role used to differentiate homologous proteins from different organisms. The domain and range for this role are 'Gene Product' and 'Organism', respectively.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C60769">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C271"/>
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C860"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Artemisinin Dimer</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Artemisinin Dimer</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A sesquiterpene lactone peroxide and dimerized plant product derived from Artemisia annua L with anti-malarial, anti-proliferative and anti-angiogenic effects. Artemisinin contains an endoperoxide moiety which forms free radicals when it reacts with iron. The resultant carbon-based radical can lead to cellular damage and cell death by reacting with cellular macromolecules such as proteins and membrane lipids. Malaria parasites contain large amounts of heme-iron, a product from the digestion of hemoglobin. However, recently it has been suggested that activation of artemisinin inside the parasite is by ferrous iron. Furthermore, due to their rapid rate of division, cancer cells require and uptake a large amount of iron to proliferate, therefore they are more susceptible to the cytotoxic effect of artemisinin than non-cancerous cells. The dimer configuration has been shown to increase compound stability and reduce general toxicity.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C42698">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C20181"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Terminology Entity</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Terminology Entity</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Terminology entities represent the elements that form and define an ontology.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Adherencia_medicacion">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Adherencia"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Adherencia_medicacion</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Definición de la Real Academia Nacional de Medicina: Nivel de coincidencia entre la conducta del paciente y la prescripción. Supone una voluntad activa por parte del paciente así como la aceptación del tratamiento prescrito. Representa el paso previo para alcanzar un buen cumplimiento.', 'Proceso por el cual los pacientes toman su medicación tal y como ha sido prescrita. Consta de tres fases diferenciadas: iniciación, implementación y discontinuación [1]. 

La no adherencia del paciente a la medicación puede encontrarse en situaciones (o combinación de ellas) como: no comenzar o retrasar el inicio del tratamiento prescrito, implementación del régimen por debajo de lo ideal o discontinuación precoz del tratamiento. Se distingue entre no adherencia primaria y secundaria:

-La no adherencia primaria se produce cuando los proveedores prescriben la medicación al paciente pero el medicamento nunca se obtiene, estando en posición de poder obtenerlo (ya que tienen la receta médica) tanto como por primera vez como en caso de renovación de la receta [1]. 

-La no adherencia secundaria se produce cuando la medicación no está siendo administrada en el paciente como es debido, estando en posesión del fármaco en cuestión. Por ejemplo, se produce cuando se toma una dosis incorrecta o a horas incorrectas, cuando se olvida tomar una o varias dosis, cuando se aumenta la frecuencia de la dosis y cuando se suspende el tratamiento demasiado pronto, bien dejando de tomarlo antes de la fecha recomendada por el médico o no obteniendo una nueva prescripción [2].

Existe otra clasificación de la falta de adherencia desde el punto de vista del paciente que puede ser intencionada o no intencionada:

- Intencionada: El paciente decide no tomarse el tratamiento por diferentes miotivos. Por ejemplo los efectos adversos, la percepción deficiente de los beneficios para la salud o la confusión por la complegidad del régimen entre otros.

- No intencionada: El paciente quiere tomar el tratamiento pero al final no lo toma. Por ejemplo por complejidades de la vida diaria o bien por olvidos. [3]

En relación a la presentación de informes sobre la adehsión a los medicamentos existe una guía llamada EMERGE creada por ala ESPACOMP (Sociedad Europea para la Adhesión, cumplimiento y la persistencia del paciente) [4]

Las consecuencias de una mala adherencia a la medicación son, entre otras

- Que el tratamiento sea ineficaz.
- Aumento de la morbilidad y mortalidad de los pacientes.
- Aumento de los costes sanitarios [5]

[1] Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., … Urquhart, J. (2012). A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology, 73(5), 691–705. https://doi.org/10.1111/j.1365-2125.2012.04167.x
[2] Martínez Mir, F., &amp; Palop Larrea, V. (2004). Adherencia al tratamiento en el paciente anciano. Información Terapéutica Del Sistema Nacional de Salud, 28(5), 113–120. https://doi.org/10.4321/S2254-28842012000400010
[3] Davies, M. J., Kotadia, A., Mughal, H., Hannan, A., &amp; Alqarni, H. (2015). The attitudes of pharmacists, students and the general public on mHealth applications for medication adherence. Pharmacy practice, 13(4).
[4] Grounded, A. R. G. E. (2018). ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Ann Intern Med, 169, 30-35. 
[5] Ahmed, R., &amp; Aslani, P. (2014). What is patient adherence? A terminology overview. International journal of clinical pharmacy, 36(1), 4-7.', '418633004 | cumplimiento con la medicación (entidad observable) |'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_SP</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <owl:disjointWith>
      <rdf:Description rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C20189">
        <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Property or Attribute</rdfs:label>
        <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Property or Attribute</ns2:synonym>
        <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A distinguishing quality or prominent aspect of a person, object, action, process, or substance.'</ns2:definition>
        <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
      </rdf:Description>
    </owl:disjointWith>
    <owl:disjointWith>
      <rdf:Description rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C3910">
        <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Molecular Abnormality</rdfs:label>
        <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Molecular Alteration, Genetic Abnormality, Molecular Abnormality, Cytogenetic or Molecular Genetic Abnormality, Chromosomal, Gene, or Protein Abnormality, MOLECULAR_ABNORMALITY</ns2:synonym>
        <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A molecular or cytogenetic abnormality which occurs in either human disease states or disease models.'</ns2:definition>
        <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
      </rdf:Description>
    </owl:disjointWith>
    <owl:disjointWith>
      <rdf:Description rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28389">
        <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C167277"/>
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCI Administrative Concept</rdfs:label>
        <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCI Administrative Concept</ns2:synonym>
        <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'An entity which is used by NCI for administrative, financial or organizational purposes.'</ns2:definition>
        <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
      </rdf:Description>
    </owl:disjointWith>
    <owl:disjointWith>
      <rdf:Description rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C14250">
        <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organism</rdfs:label>
        <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">BiologicEntity, organism, Organismal, Taxon, Organism, Organisms</ns2:synonym>
        <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A living entity.'</ns2:definition>
        <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
      </rdf:Description>
    </owl:disjointWith>
    <owl:disjointWith>
      <rdf:Description rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28428">
        <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Retired Concept</rdfs:label>
        <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">isRetired, Retired Concept, All Retired Concepts, Retired Concepts</ns2:synonym>
        <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Concept has been retired, and should not be used except to deal with old data.'</ns2:definition>
        <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
      </rdf:Description>
    </owl:disjointWith>
    <owl:disjointWith>
      <rdf:Description rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C97325">
        <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Manufactured Object</rdfs:label>
        <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Manufactured Object</ns2:synonym>
        <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A physical object created by hand or machine.'</ns2:definition>
        <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
      </rdf:Description>
    </owl:disjointWith>
    <ns1:P97 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A protein, RNA or a complex that contains proteins and/or RNA.</ns1:P97>
    <ns1:P207 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">C1704222</ns1:P207>
    <ns1:P108 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene Product</ns1:P108>
    <ns1:code rdf:datatype="http://www.w3.org/2001/XMLSchema#string">C26548</ns1:code>
    <ns1:P366 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product</ns1:P366>
    <ns1:P90 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Genome Encoded Entity</ns1:P90>
    <ns1:P106 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Classification</ns1:P106>
    <ns1:P98 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">In NCI Thesaurus: includes Proteins, Functional RNAs, Protein Complexes, and Riboprotein Complexes</ns1:P98>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene Product</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Genome Encoded Entity, Gene Product</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A protein, RNA or a complex that contains proteins and/or RNA.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Tipos_indicadores">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Indicadores"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tipos_indicadores</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Trabajamos con métodos directos e indirectos, con distinto grado de objetividad, en los que se requiere la presencia física del paciente ante el personal sanitario o no, pueden ser escritos o verbales y pueden ser métodos de medida continua o discontinua en el tiempo. 

Por ello, se pueden clasificar los métodos en:
- Directos/Indirectos 
- Objetivos/Subjetivos 
- Continuos/discontinuos en el tiempo
- Presenciales/online
- Escritos/verbales

Se añade una o varias de estas características para cada método que tenga referencia científica sobre esta clasificación.', '- Definición de la Real Academia Nacional de Medicina de 'Indicador': 

Que indica o sirve para indicar algo.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_SP</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Adherencia">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Adherencia</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'- Definición de la Real Academia Española de 'Adherencia':

Cualidad de adherente.', '405078008 | conducta relacionada con el cumplimiento (entidad observable) |', 'El grado en que el comportamiento de las personas (incluida la toma de medicamentos) se corresponde con las recomendaciones acordadas por un proveedor de atención médica, es decir, el grado de cumplimiento. 

El grado en que el comportamiento de una persona a la hora de tomar su medicación, seguir un régimen alimenticio y/o ejecutar ciertos cambios en los hábitos cotidianos, se corresponde con las recomendaciones acordadas con el personal sanitario. La  adherencia conlleva adoptar una actitud concreta ante ciertas actividades relacionadas con el tratamiento terapeútico. En este caso, se considera que para ser un paciente adherente, se debe alcanzar un comportamiento adecuado a la hora de, por ejemplo: buscar atención médica; surtir recetas y tomar correctamente la medicación; vacunarse; ir a las citas de seguimiento; ejecutar ciertos hábitos para mantener la higiene personal, controlar el asma, diabetes y el tabaco; utilizar anticonceptivos cuando sea requerido y no mantener una conducta sexual de riesgo; y tener una dieta equilibrada en combinación con una actividad física adecuada.  [1]

Ya desde 1997, la asociación 'American Heart Association' afirmaba que la adherencia de los pacientes dependía fuertemente de la relación del paciente con su entorno: un mínimo de conocimiento, motivación, habilidad y recursos son necesarios para poder seguir las recomendaciones de los doctores.

[1] E. Sabat´e. (2003). Adherence to Long-Term Therapies: Evidence for Action. World Health Organization, Geneva, Switzerland.', 405078008</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_SP</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Directo/indirecto">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Tipos_indicadores"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Directo/indirecto</rdfs:label>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_SP</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://semanticscience.org/resource/SIO_010004">
    <rdfs:subClassOf rdf:resource="http://semanticscience.org/resource/SIO_000004"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">chemical entity</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A chemical entity is a material entity that pertains to chemistry.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GEXO</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://semanticscience.org/resource/SIO_000004">
    <rdfs:subClassOf rdf:resource="http://semanticscience.org/resource/SIO_000003"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">material entity</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A material entity is a physical entity that is spatially extended, exists as a whole at any point in time and has mass.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GEXO</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43792">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43643"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Has_Associated_Anatomy</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Has_Associated_Anatomy</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A role used to specify physical structures or typical subcellular locations of a gene product. The domain and range for this role are 'Gene Product' and 'Anatomic Structure, System, or Substance', respectively.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Factores_influyentes">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Adherencia_medicacion"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Factores_influyentes</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'- Definición de la Real Academia Española de 'Factor':

Elemento o causa que actúan junto con otros.

- Definición de la Real Academia Española de 'Influyente':

Que influye.', 'La adherencia es un fenómeno multidimensional en el que intervienen diferentes tipos de factores: 
1) Factores socio-económicos
2) Factores relativos al sistema proveedor de los servicios sanitarios 
3) Factores terapeúticos
4) Factores inherentes al paciente
5) Factores referidos a la condición de enfermo
6) Factores sociodemográficos
7) Enfermedad

No son disjuntos puesto que pueden influenciarse entre sí.

[1] E. Sabat´e. (2003). Adherence to Long-Term Therapies: Evidence for Action. World Health Organization, Geneva, Switzerland.
[2] Lee, C. S., Tan, J. H. M., Sankari, U., Koh, Y. L. E., &amp; Tan, N. C. (2017). Assessing oral medication adherence among patients with type 2 diabetes mellitus treated with polytherapy in a developed Asian community: a cross-sectional study. BMJ Open, 7(9), e016317. http://doi.org/10.1136/bmjopen-2017-016317
[3] Ramos Morales, L. E. (2015). La adherencia al tratamiento en las enfermedades crónicas. Revista Cubana de Angiología y Cirugía Vascular, 16(2), 175-189.', 'Forman parte de la Guía de Adherencia a la Medicación EMERGE (Item 9b)

[1] Grounded, A. R. G. E. (2018). ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Ann Intern Med, 169, 30-35.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_SP</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43794">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43643"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Has_Chemical_Classification</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Has_Chemical_Classification</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A role used to specify the physical structure type of a protein molecule (e.g. metalloprotein, transmembrane protein). Both the domain and range for this role are 'Gene Product'.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43799">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43643"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Is_Biomarker_Type</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Is_Biomarker_Type</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A role used to designate the type of biomarker a gene product is; it points to a small tree of biomarker types (e.g., Disease Marker, Metabolic Marker, Prognostic Marker). The domain and range for this role are 'Gene Product' and 'Diagnostic or Prognostic Factor', respectively.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43802">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43643"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Malfunction_Associated_With_Disease</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Malfunction_Associated_With_Disease</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A role used to indicate that molecular abnormalities in a gene product may be associated with the manifestation of a disease. The role is used to assert a link between a gene product and a disease when the association is considered to have clinical relevance. The domain and range for this role are 'Gene Product' and 'Disease, Disorder or Finding', respectively.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C20027">
    <ns1:P310 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Header_Concept</ns1:P310>
    <ns1:P97 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organizing term for the Proteins tree</ns1:P97>
    <ns1:P207 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">C0815043</ns1:P207>
    <ns1:P108 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein, Organized by Function</ns1:P108>
    <ns1:code rdf:datatype="http://www.w3.org/2001/XMLSchema#string">C20027</ns1:code>
    <ns1:P366 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein_Organized_by_Function</ns1:P366>
    <ns1:P90 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proteins [By Function]</ns1:P90>
    <ns1:P106 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Classification</ns1:P106>
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C17021"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein, Organized by Function</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proteins [By Function], Protein, Organized by Function</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Organizing term for the Proteins tree'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlos/ontologies/2019/3/untitled-ontology-31#Indicators">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlos/ontologies/2019/3/untitled-ontology-31#Medication_adherence"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Indicators</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'We found different ways to measure the level of adherence of a medicated patient. Each method has its advantages and disadvantages and some show greater objectivity than others. In addition, some methods have more limitations when it comes to being implemented: either because they require a larger budget, because they require a complex infrastructure, because a certain cognitive level or skills are required to perform the measurement correctly... [1]

Of all the possible existing methods for studying adherence in research, clinical practice and epidemiological studies, Lee C et al. conclude that the most commonly used are self-evaluation methods (questionnaires, scales...), 'electronic measures', data extracted from insurance claims and prescription renewals, and pill counts.  However, as we have already commented, since each method has a number of advantages and disadvantages and not all are applicable under all circumstances, it is necessary to admit that there is no single correct way to measure adherence and no independent and completely conclusive indicator, but that it is necessary to triangulate often between several of them [2].

Here we analyze methods of different types: direct and indirect, with different degrees of objectivity, in which the physical presence of the patient is required before the health personnel or not, they can be written or verbal and they can be methods of continuous or discontinuous measurement in time. We consider that these methods are disjointed from each other since each type of indicator has a series of specific properties that make some methods more recommended in some circumstances than others. 

[1] Rodríguez Chamorro, M. Á., García-Jiménez, E., Gil, A. B., Chamorro, A. R., Pérez Merino, E. M., Faus Dáder, M. J., &amp; Martínez Martínez, F. (2009). Herramientas para identificar el incumplimiento farmacoterapéutico desde la farmacia comunitaria Tools for the identification by community pharmacies of pharmacotherapeutic non-compliance. Pharmaceutical Care España, 11(4), 183–191.
[2] Lee, C. S., Tan, J. H. M., Sankari, U., Koh, Y. L. E., &amp; Tan, N. C. (2017). Assessing oral medication adherence among patients with type 2 diabetes mellitus treated with polytherapy in a developed Asian community: a cross-sectional study. BMJ Open, 7(9), e016317. https://doi.org/10.1136/bmjopen-2017-016317', 'The indicators are part of the EMERGE Guide to Adherence to Medication (Item 1c).

[1] Grounded, A. R. G. E. (2018). ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Ann Intern Med, 169, 30-35.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_EN</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C17728">
    <ns1:P97 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">General term for proteins that have binding as a major function.</ns1:P97>
    <ns1:P207 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">C0242210</ns1:P207>
    <ns1:P325 rdf:datatype="http://www.w3.org/2001/XMLSchema#string"><![CDATA[<ncicp:ComplexDefinition xmlns:ncicp='http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#'><ncicp:def-definition>general term for class of proteins whose most important function appears to be binding of some ligand for solubility, transport, bioactivity regulation, or other nonenzymatic process; prefer NTs whenever possible.</ncicp:def-definition><ncicp:def-source>CSP2000</ncicp:def-source></ncicp:ComplexDefinition>]]></ns1:P325>
    <ns1:P108 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ligand Binding Protein</ns1:P108>
    <ns1:code rdf:datatype="http://www.w3.org/2001/XMLSchema#string">C17728</ns1:code>
    <ns1:P366 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ligand_Binding_Protein</ns1:P366>
    <ns1:P90 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Binding Protein</ns1:P90>
    <ns1:P106 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Amino Acid, Peptide, or Protein</ns1:P106>
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C20027"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ligand Binding Protein</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ligand Binding Protein, Binding Protein</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'General term for proteins that have binding as a major function.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Interacciones">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Detalles_clinicos_medicamentos"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Interacciones</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Definición de la Real Academia Nacional de Medicina de 'Interacción medicamentosa':

Modificación favorable o perjudicial del efecto de un fármaco por la administración anterior o simultánea de otro fármaco, alimento o bebida, o por la presencia de algún compuesto químico ambiental.', 'Según la norma ISO 11615, esta clase puede usarse para describir las interacciones de un medicamento (con otro medicamento) y otras formas de interacción tal y como se describe en la información reglamentaria del producto.', '404204005 | Interacción medicamentosa  |'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_SP</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43740">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43643"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chemical_Or_Drug_Is_Metabolized_By_Enzyme</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chemical_Or_Drug_Is_Metabolized_By_Enzyme</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A role used to specify that an enzyme is directly responsible for metabolizing a chemical or drug into an active form, inactive form, or both. The domain and range for this role are 'Drug, Food, Chemical or Biomedical Material' and 'Gene Product', respectively.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Terapeuticos">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Factores_influyentes"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Terapeuticos</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Varios de los factores que interfieren en el grado de adherencia al tratamiento farmacológico se agrupan en los llamados factores terapeúticos. La complejidad del tratamiento, su duración o la frecuencia con la que el régimen de medicamentos es cambiado por el sanitario responsable de ello, son factores influyentes en el grado de adherencia del paciente, aunque no solo nos restringimos a ellos. Es igualmente importante conocer si el paciente posee un historial de tratamientos que no hayan sido efectivos y/o si el paciente no percibe de forma inmediata los beneficios de los medicamentos. Además, los efectos secundarios adversos tienen relevancia a la hora de evaluar los motivos de la falta de adherencia, entre otros. Sería importante que estuviese a disposición de los pacientes un servicio médico que les ayude a lidiar con dichos efectos [1].

También se ha demostrado que una frecuencia de administración del medicamento superior a dos veces diarias incentiva la mala o insuficiente adherencia del paciente [2].

Otros factores terapéuticos relacionados con la falta de adherencia a la medicación son la polimedicación, las medicaciones diarias [3] y las interacciones entre medicamentos [4].

El aspecto de los envases, las dosis, el tamaños de las píldoras y todas las características físicas de las píldoras son también características importantes para una buena adhesión al tratamiento [5].

[1] De Geest, S., &amp; Sabaté, E. (2003). Adherence to long-term therapies: Evidence for action. European Journal of Cardiovascular Nursing, 2(4), 323. https://doi.org/10.1016/S1474-5151(03)00091-4
[2] Capoccia, K., Odegard, P. S., &amp; Letassy, N. (2016). Medication Adherence With Diabetes Medication: A Systematic Review of the Literature. The Diabetes Educator, 42(1), 34–71. https://doi.org/10.1177/0145721715619038
[3] Karanasiou, G. S., Tripoliti, E. E., Papadopoulos, T. G., Kalatzis, F. G., Goletsis, Y., Naka, K. K., ... &amp; Fotiadis, D. I. (2016). Predicting adherence of patients with HF through machine learning techniques. Healthcare technology letters, 3(3), 165-170. 
[4] Wuyts, J., Maesschalck, J., De Wulf, I., Foubert, K., Boussery, K., De Lepeleire, J., &amp; Foulon, V. (2018). Studying the impact of a medication use evaluation for polymedicated older patients by the community pharmacist (SIMENON): study protocol. BMC health services research, 18(1), 623.
[5] Martín Alfonso, L. (2006). Repercusiones para la salud pública de la adherencia terapéutica deficiente. Revista Cubana de Salud Pública, 32(3), 0-0.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_SP</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C271">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C277"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Antimalarial Agent</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Anti-Malarial Drug, Antimalarial Agent, Anti-Malarial Agent, Antimalarials, Antimalarial Drugs</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Agents used to treat malaria, and are usually classified based on action against plasmodia at different stages in their life cycle in the human.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43800">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43643"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Is_Element_In_Pathway</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Is_Element_In_Pathway</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A role used to assert a relationship between a gene product and a biochemical pathway in which it participates. This relationship is used only when a gene product has been implicated in a pathway by the curated source (Biocarta, KEGG or PID). The domain and range for this role are 'Gene Product' and 'Biochemical Pathway', respectively.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://semanticscience.org/resource/SIO_010441">
    <rdfs:subClassOf rdf:resource="http://semanticscience.org/resource/SIO_010004"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">submolecule</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A submolecule is a mereological sum of a collection of covalently bonded atoms.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GEXO</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43639">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C42698"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCI Thesaurus Entity</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCI Thesaurus Entity</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'The terminology entities that represent the elements that form and define the NCI Thesaurus.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43798">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43643"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Is_Biomarker_Of</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Is_Biomarker_Of</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A role used to indicate that presence of a gene product may contribute to clinical diagnosis, treatment selection, or prediction of clinical outcome. The domain and range for this role are 'Gene Product' and 'Disease, Disorder or Finding', respectively.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlos/ontologies/2019/3/untitled-ontology-31#Medication_adherence">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlos/ontologies/2019/3/untitled-ontology-31#Adherence"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Medication_adherence</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'418633004 | Medication adherence |', 'The process by which patients take their medication as prescribed. It consists of three distinct phases: iniciation, implementation and discontinuation [1].

The patient's non-adherence to the medication may be found in situations (or combination of them) such as: not starting or delaying the start of the prescribed treatment, implementation of the regimen below ideal or early discontinuation of treatment. A distinction is made between primary and secondary non-adherence:

- Primary non-adherence occurs when providers prescribe medication to the patient but the medication is never obtained, being in position to obtain it (since they have the prescription) as much as for the first time as in the case of of prescription renewal [1].

- Secondary non-adherence occurs when the medication is not being administered properly to the patient, being in possession of the drug in question. For example, it occurs when an incorrect dose is taken or at incorrect times, when one or some doses are forgotten, when the frequency of the dose is increased and when treatment is stopped too soon, either bu stopping it before the date recommended by the doctor or by not getting a new prescription [2].

There is another clasification of lack of adherence from the patient's point of view that may be intentional or unintentional:

- Intentional: the patient decides not to take the treatment for different reasons. For example adverse effects, poor perception of health benefits or confusion due to the completeness of the regimen, among others.

- Unintentional: the patient wants to take the treatment but in the end does not take it. For example, because of the complexities of daily life or because of fogetfulness [3].

In relation to reporting on medication adherence 
there is a guide called EMERGE created by ESPACOMP (European Society for Patient Adherence, Compliance and Persistence) [4].

The consequences of poor medication adherence are, among others:

- The treatment is ineffective.
- Increased patient morbidity and mortality.
- Increased healthcare costs [5].

[1] Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., … Urquhart, J. (2012). A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology, 73(5), 691–705. https://doi.org/10.1111/j.1365-2125.2012.04167.x
[2] Martínez Mir, F., &amp; Palop Larrea, V. (2004). Adherencia al tratamiento en el paciente anciano. Información Terapéutica Del Sistema Nacional de Salud, 28(5), 113–120. https://doi.org/10.4321/S2254-28842012000400010
[3] Davies, M. J., Kotadia, A., Mughal, H., Hannan, A., &amp; Alqarni, H. (2015). The attitudes of pharmacists, students and the general public on mHealth applications for medication adherence. Pharmacy practice, 13(4).
[4] Grounded, A. R. G. E. (2018). ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Ann Intern Med, 169, 30-35. 
[5] Ahmed, R., &amp; Aslani, P. (2014). What is patient adherence? A terminology overview. International journal of clinical pharmacy, 36(1), 4-7.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_EN</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://semanticscience.org/resource/SIO_010035">
    <rdfs:subClassOf rdf:resource="http://semanticscience.org/resource/SIO_010441"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">gene</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A gene is part of a nucleic acid that contains all the necessary elements to encode a functional transcript.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GEXO</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://semanticscience.org/resource/SIO_000003">
    <owl:disjointWith>
      <rdf:Description rdf:about="http://semanticscience.org/resource/SIO_000260">
        <rdfs:subClassOf rdf:resource="http://semanticscience.org/resource/SIO_000000"/>
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">abstract entity</rdfs:label>
        <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'An abstract entity is an entity that exhibits zero, one or more physical manifestations.'</ns2:definition>
        <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GEXO</ns2:ontology_acronm>
      </rdf:Description>
    </owl:disjointWith>
    <rdfs:subClassOf rdf:resource="http://semanticscience.org/resource/SIO_000000"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">physical entity</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A physical entity is an entity that is spatio-temporally located (is or occupies some part of spacetime) and only has physical entities as parts.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GEXO</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43789">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43643"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Encoded_By_Gene</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Encoded_By_Gene</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A role used to assert a relationship between a gene product and the gene that encodes it. The domain and range for this role are 'Gene Product' and 'Gene', respectively.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C616">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C718"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lipid</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lipid, Lipids</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A class of hydrocarbon-containing organic compounds. Lipids are insoluble in water but soluble in nonpolar solvents and play important roles in living organisms: these roles include functioning as energy storage molecules, serving as structural components of cell membranes, and constituting important signaling molecules. Lipids can be subdivided into 2 groups: fatty acids and glycerides.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1913">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1908"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Drug or Chemical by Structure</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Drug or Chemical by Structure</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Substances that are grouped or classified by chemical composition.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <rdf:Description rdf:about="http://www.w3.org/2002/07/owl#Class">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">None</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C167277">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28428"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Retired Concept 2019</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Retired Concept 2019</ns2:synonym>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </rdf:Description>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1909">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1908"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pharmacologic Substance</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pharmacologic Substance, Agent, DRUG, Pharmacologic Agent, therapeutic agents, Pharmaceuticals, Pharmaceutical Agent, Drug Substance, Drug, drug, Pharmacological Substance, therapeutic_agents, Therapeutic Agent</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43803">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43643"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Plays_Role_In_Biological_Process</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Plays_Role_In_Biological_Process</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A role used to assert that a gene product participates in a specific biological process. The domain and range for this role are 'Gene Product' and 'Biological Process', respectively.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1908">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Drug, Food, Chemical or Biomedical Material</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Drug, Food, Chemical or Biomedical Material</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'An organic or inorganic substance, element, isotope, food or other materials derived from microorganism, plant, or animal sources. They can be used for the prevention, diagnosis, treatment or research of disease states, for industrial purposes, or for the promotion or maintenance of organism viability or health.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Detalles_clinicos_medicamentos">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Terapeuticos"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Detalles_clinicos_medicamentos</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Las normas ISO son un conjunto de normas orientadas a la gestión de una empresa en sus distintos ámbitos. Las normas ISO son establecidas por el Organismo Internacional de Estandarización (ISO), y se componen de estándares y guías relacionados con sistemas y herramientas específicas de gestión aplicables en cualquier tipo de organización. 

Las normas ISO se crearon con la finalidad de ofrecer orientación, coordinación, simpificación y unificación de criterios a las empresas y organizaciones con el objeto de reducir costes y aumentar la efectividad, así como estandarizar las normas de productos y servicios para las organizaciones internacionales.

Las normas ISO se han desarrollado y adoptado por multitud de empresas de muchos países por una necesidad y voluntad de homogeneizar las características y los parámetros de calidad y seguridad de los productos y servicios [1].

Las normas ISO 11615 se elaboraron en respuesta a una demanda mundial de especificaciones internacionales armonizadas para medicamentos. Es parte de un grupo de cinco normas ISO y cuatro especificaciones técnicas que en conjunto proporcionanm la base para la identificación única de medicamentos.

Un medicamento está asociado a un conjunto de detalles clínicos. Estos consisten en información sobre la indicación(es) del medicamento, su contraindicación(es), su efecto(s) no deseado y sus interacciones. 

Indicación(es) y contraindicación(es) pueden estar ambas restringidas por información sobre datos de población que hagan referencia a cualquier indicación o contraindicación concreta, y por información de datos de otra terapia, es decir el uso de un medicamento en relación a otro medicamento.

Los efectos no deseados son asociados directamente al medicamento o asociados al medicamento pero ligados a una indicación específica o a una población específica [2]. 

[1] https://www.isotools.org/2015/03/19/que-son-las-normas-iso-y-cual-es-su-finalidad/

[2] ISO 11615:2017'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_SP</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C860">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C552"/>
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C616"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Terpene Compound</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">terpene, Terpenes, Terpene Compound</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'The class of compound known as terpenes comprise of essential oils, flavours and fragrances. The extraction and synthesis of compounds such as these is the basis for the perfumery industry. They find a variety of uses in the food and pharmaceutical industry as flavour and odour improvers'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43734">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43643"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chemical_Or_Drug_Affects_Gene_Product</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chemical_Or_Drug_Affects_Gene_Product</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A role used to assert that a gene product is the target of a therapeutic agent. The role implies a direct interaction between the product and the therapeutic agent but it does not specify the type of association (e.g., involvement, interference, inhibition or cleavage). The domain and range for this role are 'Drug, Food, Chemical or Biomedical Material' and 'Gene Product', respectively.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43801">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43643"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Is_Physical_Part_Of</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Is_Physical_Part_Of</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A role used to indicate that a gene product normally functions as a component of a 'functional complex'. Both the domain and range for this role are 'Gene Product'.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43791">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43643"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Has_Abnormality</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Has_Abnormality</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A role used to establish a link between a gene product and the molecular abnormalities that are observed in human cells and tissues in association with diseases such as cancers (e.g., over or under-expression of gene product). The domain and range for this role are 'Gene Product' and 'Molecular Abnormality', respectively.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlos/ontologies/2019/3/untitled-ontology-31#Autoevaluations">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlos/ontologies/2019/3/untitled-ontology-31#Indicators"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Autoevaluations</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'These are subjective methods that, although often accused of being inaccurate or untrue, present advantages that make them be chosen over others (they have low cost, are usually simple to implement, provide information in real time...). [1,2,3].

In addition, they also allow us to better contextualize the patient's situation in order to subsequently adapt a better intervention or action plan [4]. 

[1] S. M. Lavsa, A. Holzworth, and N. T. Ansani. (2011). Selection of a validated scale for measuring medication adherence. Journal of the American Pharmacists Association, vol. 51, no. 1, pp. 90–94. https://doi.org/10.1331/JAPhA.2011.09154
[2] Nguyen, T. M. U., Caze, A. La, &amp; Cottrell, N. (2014). What are validated self-report adherence scales really measuring?: A systematic review. British Journal of Clinical Pharmacology, 77(3), 427–445. https://doi.org/10.1111/bcp.12194
[3] Morisky, D. E., Ang, A., Krousel-Wood, M., &amp; Ward, H. J. (2008). Predictive validity of a medication adherence measure in an outpatient setting. Journal of Clinical Hypertension, 10(5), 348–354. https://doi.org/10.1111/j.1751-7176.2008.07572.x
[4] B. L. Svarstad, B. A. Chewning, B. L. Sleath, and C. Claesson. (1999). The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Education &amp; Counseling, vol. 37, no. 2, pp. 113–124.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_EN</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C17021">
    <ns1:P97 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence.</ns1:P97>
    <ns1:P207 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">C0033684</ns1:P207>
    <ns1:P368 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">CHEBI:36080</ns1:P368>
    <ns1:P325 rdf:datatype="http://www.w3.org/2001/XMLSchema#string"><![CDATA[<ncicp:ComplexDefinition xmlns:ncicp='http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#'><ncicp:def-definition>A molecule made up of amino acids that are needed for the body to function properly. Proteins are the basis of body structures such as skin and hair and of substances such as enzymes, cytokines, and antibodies.</ncicp:def-definition><ncicp:def-source>NCI-GLOSS</ncicp:def-source></ncicp:ComplexDefinition>]]></ns1:P325>
    <ns1:P108 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein</ns1:P108>
    <ns1:code rdf:datatype="http://www.w3.org/2001/XMLSchema#string">C17021</ns1:code>
    <ns1:P366 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein</ns1:P366>
    <ns1:P90 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein (NOS)</ns1:P90>
    <ns1:P90 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proteins</ns1:P90>
    <ns1:P106 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Amino Acid, Peptide, or Protein</ns1:P106>
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26548"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">protein, Protein, Protein (NOS), Proteins</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C277">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C276"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Antiprotozoal Agent</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Antiprotozoal Agent, Antiprotozoal Drugs</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A pharmacological agent that can kill or prevent the reproduction of parasitic protozoans.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C718">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1913"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organic Chemical</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organic Chemical</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Molecule that contains atoms of the element carbon, usually combined with itself and with atoms of one or more other element such as hydrogen, oxygen, nitrogen, sulfur, phosphorus, chlorine, or fluorine. Excludes carbides, carbonates and carbon oxides.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Sociodemograficos">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Factores_influyentes"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sociodemograficos</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Una gran variedad de factores que interfieren en el grado de adherencia al tratamiento farmacológico se pueden agrupar como 'factores sociodemográficos'. Existe, respecto a estos, cierta disparidad de argumentos acerca de su importancia o relevancia en el grado de adherencia de los pacientes. [1]

La raza de las personas ha sido considerada en algunos casos como factor influyente diferenciando si el paciente en inmigrante o no. Además, también tiene cierta implicación en el grado de adherencia, las convicciones culturales detrás de cada raza [2] aunque a menudo se ven enmascaradas como desigualdades sociales [3]. 

Otro factor socieodemográfico como la guerra (incluso cuando esta ha finalizado oficialmente) influye de diferentes fromas: en la medida en que la economía del paciente se haya resentido, en la falta de control médico, en el anarquismo existente... [1]

La edad es un aspecto estudiado para estos casos pero no se termina de definir completamente en cuanto a su influencia en la adherencia se refiere. Esto se debe a las interferencias con otras características del paciente (si vive solo o no, si depende de sus padres o no, si reside en país desarrollado o no,[3] etc.). Hay estudios que sugieren menor adherencia en adolescentes que en niños más jóvenes [4] y que el grado de adherencia de niños pequeños depende de los padres o tutores encargados del niño. Respecto a esto, el nivel de adherencia puede verse afectado también en la medida en que el niño crece y va cambiando su entorno, pasando menos tiempo en casa y en familia e influyéndose más por el resto de la sociedad [1].

Parece que aplicar medidas concretas (repartir la responsabilidad de seguir el tratamiento fielmente entre los familiares cercanos, marcar objetivos, dar recompensas...) en casos en los que los pacientes son jóvenes, resulta en un incremento de la adherencia [5].

En la adolescencia se registra menor nivel de adherencia, probablemente como respuesta de rebelión ante el control del tratamiento. Además, aquellos jóvenes que asumen responsabilidades de forma prematura, suelen demostrar menor adherencia aún. Para remediar esto, se debe intentar minimizar los conflictos del enfermo adolescente con los padres, sin que decaiga el involucramiento de estos en seguir las pautas del tratamiento. Por ejemplo, esfuerzos en educar a los padres sobre la actitud de sus hijos adolescentes ante la enfermedad que pudiesen estar padeciendo para mantener una buena relación en la familia, mejorarían la adherencia [1].

Respecto a las personas mayores, nos encontramos con el problema de que el paciente suele padecer mayor número de enfermedades y por tanto, el régimen terapeútico se complica. Además, la presencia de discapacidades congnitivas aumenta el riesgo de reducción de la adherencia al tratamiento en estas personas.  Según Eney y Goldstein E. [6], los ancianos son responsables de la mitad de las prescripciones efectuadas en países desarrollados y de más de la mitad de los costes médicos, siendo un grupo minoritario en la sociedad.

[1] De Geest, S., &amp; Sabaté, E. (2003). Adherence to long-term therapies: Evidence for action. European Journal of Cardiovascular Nursing, 2(4), 323. https://doi.org/10.1016/S1474-5151(03)00091-4 
[2] Morgan, M., &amp; Watkins, C. J. (1988). Managing hypertension: beliefs and responses to medication among cultural groups. Sociology of Health &amp; Illness, 10(4), 561–578. http://doi.org/10.1111/1467-9566.ep10837256
[3] Belgrave LL. (1997). Race and compliance with hypertension treatment. Sociological Abstracts no. 45. American Sociological Association.
[4] Fotheringham, M. J. and Sawyer, M. G. (1995), Adherence to recommended medical regimens in childhood and adolescence. Journal of Paediatrics and Child Health, 31: 72–78. http://dx.doi.org/10.1111/j.1440-1754.1995.tb00750.x
[5] Michael A. Rapoff. (2010). Adherence to Pediatric Medical Regimens.Springer US. doi: 10.1007/978-1-4419-0570-3
[6] Eney, R., &amp; Goldstein, E. (1976). Compliance of chronic asthmatics with oral administration of theophylline as measured by serum and salivary levels. Pediatrics, 57(4), 513–7. Retrieved from http://pediatrics.aappublications.org/content/57/4/513.short', 'Forman parte de la Guía para la Adhesión a la Medicación EMERGE (Item 4a)

[1] Grounded, A. R. G. E. (2018). ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Ann Intern Med, 169, 30-35.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_SP</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Indicadores">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Adherencia_medicacion"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Indicadores</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'- Definición de la Real Academia Nacional de Medicina de 'Indicador':

Que indica o sirve para indicar algo.', 'Los indicadores forman parte de la Guía para la Adherencia a la Medicación EMERGE (Item 1c)

[1] Grounded, A. R. G. E. (2018). ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Ann Intern Med, 169, 30-35.', 'Encontramos distintas formas de medir el nivel de adherencia de un paciente medicado. Cada método tiene sus ventajas y desventajas y algunos muestran mayor objetividad que otros. Además, algunos métodos presentan más limitaciones a la hora de ser implementados: ya sea porque requieren mayor presupuesto, porque precisan de infraestructura compleja, porque se requiera un nivel cognitivo o habilidades determinadas para realizar la medición correctamente... [1]

De todos los posibles métodos existentes para estudiar la adherencia en el campo de la investigación, la práctica clínica y en los estudios epidemológicos, Lee C et al. concluyen que los más utilizados son los métodos de autoevaluación (cuestionarios, escalas...), 'electronic measures', los datos extraídos a partir de los reclamos del seguro y de las renovaciones de prescripciones y el conteo de píldoras.  Sin embargo y como ya hemos comentado, puesto que cada método conlleva a una serie de ventajas e inconvenientes y no todos son aplicables bajo todas las circunstancias, es necesario admitir que no existe una única forma correcta de medir la adherencia ni un indicador independiente y completamente concluyente, sino que es necesario triangular a menudo entre varios de ellos [2].

Aquí analizamos métodos de distintos tipos: directos e indirectos, con distinto grado de objetividad, en los que se requiere la presencia física del paciente ante el personal sanitario o no, pueden ser escritos o verbales y pueden ser métodos de medida continua o discontinua en el tiempo. Consideramos que son métodos disjuntos entre sí  puesto que cada tipo de indicador cuenta con una serie de propiedades específicad que hace que unos métodos sean más recomendados en unas circunstancias que otros. 

[1] Rodríguez Chamorro, M. Á., García-Jiménez, E., Gil, A. B., Chamorro, A. R., Pérez Merino, E. M., Faus Dáder, M. J., &amp; Martínez Martínez, F. (2009). Herramientas para identificar el incumplimiento farmacoterapéutico desde la farmacia comunitaria Tools for the identification by community pharmacies of pharmacotherapeutic non-compliance. Pharmaceutical Care España, 11(4), 183–191.
[2] Lee, C. S., Tan, J. H. M., Sankari, U., Koh, Y. L. E., &amp; Tan, N. C. (2017). Assessing oral medication adherence among patients with type 2 diabetes mellitus treated with polytherapy in a developed Asian community: a cross-sectional study. BMJ Open, 7(9), e016317.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_SP</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C552">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C718"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hydrocarbon</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">hydrocarbon, Hydrocarbon, Hydrocarbons</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A group of organic compounds that consist of only hydrogen (H) and carbon (C) atoms and are involved in energy production. They may be cyclic or non-cyclic compounds. They may have double bonds, single bonds or both with carbon forming the backbone.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Dispositivos_electronicos">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Indicadores"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dispositivos_electronicos</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Son un tipo de indicador indirecto [1] y objetivo [2].

[1] Chamorro, M. A. R., García-Jiménez, E., Amariles, P., &amp; Faus, M. J. (2008). Revisión de tests de medición del cumplimiento terapéutico utilizados en la práctica clínica. Aten Primaria, 40(8), 413–417.
[2] Nguyen, T. M. U., Caze, A. La, &amp; Cottrell, N. (2014). What are validated self-report adherence scales really measuring?: A systematic review. British Journal of Clinical Pharmacology, 77(3), 427–445. https://doi.org/10.1111/bcp.12194', 'Forman parte de la Guía para la Adherencia a la Medicación EMERGE (Item 6a)

[1] Grounded, A. R. G. E. (2018). ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Ann Intern Med, 169, 30-35.', '- Definición de la Real Academia Nacional de Medicina de 'Dispositivo':

Instrumento o aditamento diseñados para realizar una acción o para facilitar un trabajo.

- Definición de la Real Academia Nacional de Medicina de 'Electrónico':

De la electrónica o relacionado con ella.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_SP</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43790">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43643"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Expressed_In_Tissue</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Expressed_In_Tissue</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A role used to specify that a normal tissue is the normal location for the expression of a gene product. The domain and range for this role are 'Gene Product' and 'Anatomic Structure, System, or Substance', respectively.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43793">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43643"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Has_Biochemical_Function</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Has_Biochemical_Function</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A role used to denote the biochemical activity of a gene product. Both the domain and range for this role are 'Gene Product'.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C254">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1909"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Anti-Infective Agent</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Anti-Infective Agent, AntiInfective Agents, Anti-Infective Drugs, Anti-Infective Agents, AntiInfectives, AntiInfective Drugs, Anti-Infectives</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A pharmacological agent that can kill or prevent the reproduction of infectious organisms.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43643">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43639"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCI Thesaurus Role</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Role, NCI Thesaurus Role</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A specific non-hierarchical, named relationship between concepts present in the NCI Thesaurus.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C276">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C254"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Antiparasitic Agent</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">antiparasitic, Antiparasitic Agent, Antiparasitic Drugs, Antiparasitics, Antiparasitic</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Any agent that is effective against infections caused by parasitic organisms and is able to inhibit their growth or kill them. This class consists of anthelmintics and antiprotozoals.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlos/ontologies/2019/3/untitled-ontology-31#Questionnaries_and_scales">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlos/ontologies/2019/3/untitled-ontology-31#Autoevaluations"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Questionnaries_and_scales</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Questionnaires: As Rodríguez Chamorro M. Á. et al. [1] says, the questionnaire (also known as a test or interview) is a tool that will allow us to obtain information about the problems with the medication presented by the patient. The procedure consists of asking the patient to answer previously defined questions so that, depending on their answers, the degree of compliance or adherence can be assessed. There are different types of questionnaires. Some are applicable to the patient and/or others, to their caregiver [1]. It is a type of indirect and subjective indicator, so we also have certain disadvantages [2].

[1] Rodríguez Chamorro, M. Á., García-Jiménez, E., Gil, A. B., Chamorro, A. R., Pérez Merino, E. M., Faus Dáder, M. J., &amp; Martínez Martínez, F. (2009). Herramientas para identificar el incumplimiento farmacoterapéutico desde la farmacia comunitaria.  Tools for the identification by community pharmacies of pharmacotherapeutic non-compliance. Pharmaceutical Care España, 11(4), 183–191.
[2] Lam, W. Y., &amp; Fresco, P. (2015). Medication Adherence Measures: An Overview. BioMed Research International. e217047. https://doi.org/10.1155/2015/217047

Scales: this is a type of self-assessment method (therefore indirect and subjective method) [1,2] in which patients are questioned and their questions evaluated according to a prederterminated fixed score, which makes it possible to distinguish between patients who are faithful to their therapeutic regimen and those who aren't. This is a type of self-assessment method (therefore, indirect and subjective method) [1,2] in which patients are questioned and their questions evaluated according to a prederterminated fixed score, which makes it possible to distinguish between patients who are faithful to their therapeutic regimen and those who are not. There are numerous validated scales (i.e., correlated with another objective or subjective measure) for this purpose. Each scale, depending on the number of items present, will last between 5 and 25 minutes [2]. 

[1] Jimmy, B., &amp; Jose, J. (2011). Patient medication adherence: Measures in daily practice. Oman Medical Journal, 26(3), 155–159. https://doi.org/10.5001/omj.2011.38
[2] Nguyen, T. M. U., Caze, A. La, &amp; Cottrell, N. (2014). What are validated self-report adherence scales really measuring?: A systematic review. British Journal of Clinical Pharmacology, 77(3), 427–445. https://doi.org/10.1111/bcp.1219', 'Are part of the EMERGE Medication Adherence Guide (Item 6a)

[1] Grounded, A. R. G. E. (2018). ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Ann Intern Med, 169, 30-35.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_EN</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43797">
    <rdfs:subClassOf rdf:resource="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43643"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Has_Structural_Domain_Or_Motif</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene_Product_Has_Structural_Domain_Or_Motif</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'A role used specify information about protein domains or motifs present in a protein that can give insight into protein function. The domain and range for this role are 'Gene Product' and 'Anatomic Structure, System, or Substance', respectively.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Condicion">
    <rdfs:subClassOf rdf:resource="http://www.semanticweb.org/parracarlosl27f/ontologies/2019/4/untitled-ontology-64#Factores_influyentes"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Condicion</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'Código SNOMED 'Condición': 260905004', 'Algunos de los factores que interfieren en el grado de adherencia al tratamiento farmacológico se agrupan en los llamados factores relacionados con la condición del paciente. Con ellos nos referimos a las demandas particulares que enfrenta el paciente debido a su condición de enfermo crónico. Encontramos aquí la importancia de un nivel cognitivo adecuado, así como el nivel de dependendia/independencia física del paciente (por ejemplo, si la mayor parte del tiempo, o en su totalidad, se encuentra en cama). La presencia de síntomas y su gravedad, así como la progresión de estos y de la enfermedad en sí, son factores también atendidos aquí. 

Además, si el paciente tiene alguna condición de drogodependencia, comorbilidad  o no percibe con claridad y buen juicio la importancia de seguir el tratamiento, puede perjudicar su grado de adherencia al tratamiento.

[1] De Geest, S., &amp; Sabaté, E. (2003). Adherence to long-term therapies: Evidence for action. European Journal of Cardiovascular Nursing, 2(4), 323. https://doi.org/10.1016/S1474-5151(03)00091-4', 'Definición de la Real Academia Nacional de Medicina de 'Condición':

 Carácter o manera de ser de una persona.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_SP</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://www.semanticweb.org/parracarlos/ontologies/2019/3/untitled-ontology-31#Adherence">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Adherence</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'- Definition of the Spanish Royal Academy of 'Adherence':

Adherent quality', 'The degree to which people's behavior (including taking medications) corresponds to recommendations agreed upon by a health care provider, i.e., the degree of compliance. 

The extent to which a person's behaviour when taking medication, following a diet and/or implementing certain changes in daily habits corresponds to the recommendations agreed with the healthcare provider. Adherence involves adopting a specific attitude towards certain activities related to therapeutic treatment. In this case, it is considered that in order to be an adherent patient, it is necessary to achieve adequate behaviour when, for example: seeking medical attention; filling prescriptions and taking medication correctly; getting vaccinated; going to follow-up appointments; carrying out certain habits to maintain personal hygiene, control asthma, diabetes and tobacco; using contraceptives when required and not maintaining a risky sexual behaviour; and having a balanced diet in combination with adequate physical activity.  [1]

As early as 1997, the American Heart Association stated that patient adherence depended heavily on the patient's relationship with his or her environment: a minimum of knowledge, motivation, skill, and resources are necessary in order to follow doctor's recommendations.

[1] E. Sabat´e. (2003). Adherence to Long-Term Therapies: Evidence for Action. World Health Organization, Geneva, Switzerland.', '405078008 | compliance behavior (observable entity) |'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ADHER_INTCARE_EN</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C20181">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Conceptual Entity</rdfs:label>
    <ns2:synonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Conceptual Entity</ns2:synonym>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'An organizational header for concepts representing mostly abstract entities.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCIT</ns2:ontology_acronm>
  </owl:Class>
  <owl:Class rdf:about="http://semanticscience.org/resource/SIO_000000">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">entity</rdfs:label>
    <ns2:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">'An entity is either a type that has zero or more physical manifestations or is an individual that exists in spacetime.'</ns2:definition>
    <ns2:ontology_acronm rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GEXO</ns2:ontology_acronm>
  </owl:Class>
  <rdf:Description rdf:about="http://www.w3.org/2002/07/owl#ObjectProperty">
    <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">None</rdfs:label>
  </rdf:Description>
</rdf:RDF>
